Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

Title
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
Authors
Keywords
2019-Coronavirus disease, Lopinavir, Asymptomatic infection, Eosinophil
Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 95, Issue -, Pages 183-191
Publisher
Elsevier BV
Online
2020-03-13
DOI
10.1016/j.ijid.2020.03.013

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now